OTCMKTS:HKMPF - Hikma Pharmaceuticals Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Hikma Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $24.40 0.00 (0.00 %) (As of 02/28/2020 10:12 AM ET) Add Compare Today's Range$24.40Now: $24.40▼$24.4050-Day Range$23.00MA: $23.89▼$25.8552-Week Range$20.90Now: $24.40▼$26.65Volume30 shsAverage Volume91 shsMarket Capitalization$5.88 billionP/E Ratio17.68Dividend YieldN/ABeta0.16 ProfileAnalyst RatingsAdvanced ChartHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment manufactures, markets, and sells generic injectable products for therapeutic categories, including oncology and anti-viral products to hospitals. Read More… Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:HKMPF Previous SymbolOTC:HKMPF CUSIPN/A CIKN/A Webhttp://www.hikma.com/ Phone44-20-7399-2760Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E Ratio17.68 Forward P/E Ratio16.49 P/E GrowthN/A Sales & Book Value Annual Sales$2.07 billion Price / Sales2.84 Cash Flow$1.88 per share Price / Cash Flow12.97 Book Value$7.05 per share Price / Book3.46Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees8,464 Outstanding Shares240,870,000Market Cap$5.88 billion Next Earnings Date5/28/2020 (Estimated) OptionableNot Optionable Receive HKMPF News and Ratings via Email Sign-up to receive the latest news and ratings for HKMPF and its competitors with MarketBeat's FREE daily newsletter. OTC:HKMPF Rates by TradingView Hikma Pharmaceuticals (OTCMKTS:HKMPF) Frequently Asked Questions What is Hikma Pharmaceuticals' stock symbol? Hikma Pharmaceuticals trades on the OTCMKTS under the ticker symbol "HKMPF." When is Hikma Pharmaceuticals' next earnings date? Hikma Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, May 28th 2020. View Earnings Estimates for Hikma Pharmaceuticals. What is the consensus analysts' recommendation for Hikma Pharmaceuticals? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hikma Pharmaceuticals in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Hikma Pharmaceuticals. Has Hikma Pharmaceuticals been receiving favorable news coverage? Headlines about HKMPF stock have been trending very negative on Friday, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Hikma Pharmaceuticals earned a news impact score of -3.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Hikma Pharmaceuticals. Who are some of Hikma Pharmaceuticals' key competitors? Some companies that are related to Hikma Pharmaceuticals include ASSD BRIT FOODS/ADR (ASBFY), KERRY GRP PLC/S (KRYAY), FERROVIAL S A/ADR (FRRVY), Fujitsu (FJTSY), Eisai (ESALY), A P MOLLER-MAER/ADR (AMKBY), SANDVIK AB/ADR (SDVKY), SUZUKI MTR CORP/ADR (SZKMY), UNICHARM CORP/S (UNICY), VESTAS WIND SYS/ADR (VWDRY), MICHELIN COMPAG/ADR (MGDDY), SGS (SGSOY), ATLANTIA SPA/ADR (ATASY), WILMAR INTL LTD/ADR (WLMIY) and KUEHNE & NAGEL/ADR (KHNGY). What other stocks do shareholders of Hikma Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Hikma Pharmaceuticals investors own include Hikma Pharmaceuticals (HIK), Tilray (TLRY), Myriad Genetics (MYGN), Alibaba Group (BABA), Suncor Energy (SU), ArcBest (ARCB), Avinger (AVGR), Atlantica Yield (AY), Bellerophon Therapeutics (BLPH) and BIOLINERX LTD/S (BLRX). Who are Hikma Pharmaceuticals' key executives? Hikma Pharmaceuticals' management team includes the folowing people: Mr. Said Samih Taleb Darwazah, Exec. Chairman (Age 62)Mr. Mazen Samih Taleb Darwazah, Exec. Vice Chairman & Pres of MENA (Age 61)Mr. Sigurdur Oli Olafsson Ph.D., CEO & Exec. Director (Age 50)Mr. Khalid Walid Hussni Nabilsi, Chief Financial Officer (Age 47)Dr. Surendera Tyagi, Group Chief Scientific Officer and Global Head of R&D How do I buy shares of Hikma Pharmaceuticals? Shares of HKMPF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Hikma Pharmaceuticals' stock price today? One share of HKMPF stock can currently be purchased for approximately $24.40. How big of a company is Hikma Pharmaceuticals? Hikma Pharmaceuticals has a market capitalization of $5.88 billion and generates $2.07 billion in revenue each year. The company earns $282 million in net income (profit) each year or $1.38 on an earnings per share basis. Hikma Pharmaceuticals employs 8,464 workers across the globe.View Additional Information About Hikma Pharmaceuticals. What is Hikma Pharmaceuticals' official website? The official website for Hikma Pharmaceuticals is http://www.hikma.com/. How can I contact Hikma Pharmaceuticals? Hikma Pharmaceuticals' mailing address is 1 NEW BURLINGTON PLACE, LONDON X0, W1S 2HR. The company can be reached via phone at 44-20-7399-2760 or via email at [email protected] MarketBeat Community Rating for Hikma Pharmaceuticals (OTCMKTS HKMPF)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 108 (Vote Outperform)Underperform Votes: 140 (Vote Underperform)Total Votes: 248MarketBeat's community ratings are surveys of what our community members think about Hikma Pharmaceuticals and other stocks. Vote "Outperform" if you believe HKMPF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HKMPF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/28/2020 by MarketBeat.com StaffFeatured Article: Percentage Gainers
